Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXTEND long-term eltrombopag extension study in adults with immune thrombocytopenic purpura
2006-000471-14Phase 4Completed
- Sponsor
- GSK
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of eltrombopag in immune thrombocytopenia (ITP), sponsored by GSK. Primary endpoint: Primary safety and tolerability endpoint. Started May 2006; status: completed.
02
Drugs
eltrombopag
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on 2006-000471-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000471-14.